Lucid Diagnostics (LUCD) Accumulated Expenses (2020 - 2026)

Lucid Diagnostics has reported Accumulated Expenses for 7 years, with the latest figure at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses changed N/A year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (changed N/A YoY), and the FY2025 full-year result was $2.7 million, down 3.89% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $2.2 million, down from $2.7 million in the prior quarter.
• The five-year high for Accumulated Expenses was $2.8 million in Q4 2024, with the low at $96000.0 in Q4 2023.
• Historically, Accumulated Expenses has averaged $1.7 million across 5 years, with a median of $2.2 million in 2026.
• Annual changes were most pronounced in 2022 — Accumulated Expenses soared 3416.0% — and 2023, when it plunged 89.08%.
• Lucid Diagnostics' Accumulated Expenses stood at $879000.0 in 2022, then sank by 89.08% to $96000.0 in 2023, then soared by 2846.88% to $2.8 million in 2024, then dropped by 3.89% to $2.7 million in 2025, then retreated by 19.09% to $2.2 million in 2026.
• The last three Accumulated Expenses figures came in at $2.2 million (Q1 2026), $2.7 million (Q4 2025), and $2.8 million (Q4 2024), per Business Quant data.